Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Waverley Pharma Inc V.WAVE

Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. Its primary focus is the PARP-1 program and secondary focus is the generic oncology injectable market in European Union, the United Kingdom (UK) and North America. It has entered into a license, manufacture, supply, marketing and distribution... see more

Bullboard (TSXV:WAVE)

View:
Comment by nomoneyon Aug 05, 2020 10:15am

RE:RE:RE:Scotia has the worst platform to do online banking

What really irks me is that they can't even have a message on the site saying that they are experiencing problems and working to fix them.  How many investors unfamiliar with Scotia's ...more  
Comment by bullmarketson Aug 05, 2020 10:10am

RE:L2 shows that at envy point MM could take it to 0.28

People pumping at the highs and selling at the lows -- this will be 50 cents plus this month imo. So it's a great buy in weakness 
Post by moneywinner1on Aug 05, 2020 10:00am

L2 shows that at envy point MM could take it to 0.28

I'm going to call it , expect close before the weekend at 0.25-0.29
Post by moneywinner1on Aug 05, 2020 9:02am

Chart tells all the story

Wave forming similar patterns like last time before the huge run , I expect news very soon 
Post by moneywinner1on Aug 05, 2020 8:26am

Wave’s Cancer drug approved in EU, soon FDA approval

Waverley Pharma Announces Grant of Market Authorization for Pemetrexed and Bortezomib in Multiple European Countries
Comment by Grose1987on Aug 04, 2020 5:00pm

RE:RE:RE:Pumpers plenty

Ahh you pulled the trigger. Looked like it was strong around .20 I added today aswell at .21 and .23 
Post by Dollarpeeon Aug 04, 2020 4:49pm

Fully funded Research + UofM + revenue stream + low float

Are the reasons why I am here holding tight patiently waiting for it to explode. If it's not real, it won't receive funding!! Average down to 0.24
Comment by bullmarketson Aug 04, 2020 3:52pm

RE:RE:Pumpers plenty

Ok I am in 22 average -- guess we got to wait for news. 
Post by DeadPool007on Aug 04, 2020 3:25pm

Catalyst

What's the next few catalyst we can expect for $WAVE?
Comment by north40on Aug 04, 2020 1:45pm

RE:RE:Scotia has the worst platform to do online banking

Horrible all morning! i clicked on and all my stocks,rrsp,tfsa vanished, so minor league.  missed a buy this morning on nxo, missed a sell on rvv,  is there No accountability?
Comment by bullmarketson Aug 04, 2020 1:16pm

RE:Pumpers plenty

Building a base and not much selling, might actually buy this thing since it's not selling off 
Post by Horn1369on Aug 04, 2020 1:11pm

Revenue from UK's NHS alone should be a big boost.

For the share price. We should see the numbers from EU in next Qs. GL Products: Waverley Pharma Inc. has a collaboration with Reliance Life Sciences Private Limited (RLS) part of a ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities